NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

神經血管設備、介入神經放射學的全球市場 (∼2026年):各產品 (栓塞 (線圈、流通量潛水員笪)、支架、球囊閉塞設備、血栓回收設備、微導管)、疾病區分 (中風、動脈瘤、CAS、AVM)、終端用戶、地區

Neurovascular Devices/Interventional Neurology Market by Product (Embolization(Coil, Flow Diverter), Stents, Balloon Occlusion Devices, Clot Retrievers, Microcatheters), Pathology (Stroke, Aneurysm, CAS, AVM) User - Global Forecasts to 2026

出版商 MarketsandMarkets 商品編碼 1007812
出版日期 內容資訊 英文 282 Pages
訂單完成後即時交付
價格
神經血管設備、介入神經放射學的全球市場 (∼2026年):各產品 (栓塞 (線圈、流通量潛水員笪)、支架、球囊閉塞設備、血栓回收設備、微導管)、疾病區分 (中風、動脈瘤、CAS、AVM)、終端用戶、地區 Neurovascular Devices/Interventional Neurology Market by Product (Embolization(Coil, Flow Diverter), Stents, Balloon Occlusion Devices, Clot Retrievers, Microcatheters), Pathology (Stroke, Aneurysm, CAS, AVM) User - Global Forecasts to 2026
出版日期: 2021年05月24日內容資訊: 英文 282 Pages
簡介

神經血管設備、介入神經放射學的市場規模在預測期間內預計以8.6%的年複合成長率發展,從2021年的25億美元,成長到2026年38億美元的規模。

對象患者數增加,進行中的產品開發及商品化,有利的醫療費償付環境,新興市場上醫療保健基礎設施的擴大,對有效的神經血管設備的市場需求的成長,神經血管治療領域的研究增加,對最小侵襲治療的需求增加,神經外科及最小侵襲手術的認識度高漲等要素促進該市場的成長。

各產品中,動脈瘤線圈栓塞設備的部門在預測期間內維持最大的佔有率。微創手術的採用增加,新興各國的醫療費增加,風險因素(高血壓,抽煙,高膽固醇,糖尿病,肥胖等)的發生等要素帶動該部門的成長。

本報告提供全球神經血管設備、介入神經放射學的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律規章、償付環境,專利分析,市場規模的變化、預測,各產品、疾病區分、終端用戶、地區/主要國家的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 供應鏈分析
  • 生態系統分析
  • 價值鏈分析
  • 波特的五力分析
  • 法規情形
  • 償付方案
  • 價格趨勢分析
  • COVID-19的影響
  • 專利詳細內容

第6章 市場分析、預測:各產品

  • 動脈瘤線圈栓塞、栓塞設備
    • 栓塞線圈
    • 分流器
    • 液體栓塞劑
  • 球囊腦血管新生、支架系統
    • 頸動脈支架
    • 栓塞保護設備
    • 球囊導管
  • 支援設備
    • 微導管
    • 導管導引線
  • 腦血栓除設備
    • 血栓回收設備
    • 吸引設備
    • 勒除器

第7章 市場分析、預測:各疾病種類

  • 腦動脈瘤
  • 缺血性中風
  • 頸動脈狹窄症
  • 動靜脈畸形、瘻管
  • 其他

第8章 市場分析、預測:各終端用戶

  • 醫院、外科中心
  • 門診病人照護中心
  • 研究、學術機構

第9章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 競爭情形

  • 概要
  • 主要企業的收益佔有率分析
  • 市場佔有率分析
  • 競爭領導製圖
  • Start-Ups/中小企業:競爭領導製圖
  • 主要企業的足跡分析

第11章 企業簡介

  • 主要企業
    • STRYKER CORPORATION
    • MEDTRONIC PLC
    • JOHNSON & JOHNSON
    • TERUMO
    • PENUMBRA
    • MICROPORT SCIENTIFIC CORPORATION
    • MEDIKIT CO. LTD.
    • INTEGERS HOLDING CORPORATION
    • BALT
    • KANEKA CORPORATION
    • PHENOX GMBH
    • ASAHI INTECC
    • PERFLOW MEDICAL
    • RAPID MEDICAL
    • CERUS ENDOVASCULAR
    • ACANDIS GMBH
    • EVASC
    • SENSOME
    • LEPU MEDICAL
    • IMPERATIVE CARE

第12章 附錄

目錄
Product Code: MD 1310

The neurovascular devices/ interventional neurology market size is expected to grow from an estimated USD 2.5 billion in 2021 to USD 3.8 billion by 2026, at a CAGR of 8.6%. The growing target patient population, ongoing product development, and commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across the emerging markets, growth in market demand for effective neurovascular devices, increase in research in the field of neurovascular therapies, rise in demand for minimally invasive neurosurgical procedures, and increase in awareness among neurosurgeons about minimally invasive surgical procedures are high growth prospects for the neurovascular devices/ interventional neurology market during the forecast period.

"The aneurysm coiling & embolization devices segment is expected account for the largest share of the neurovascular devices/interventional neurology market from 2021 to 2026."

On the basis of product, the neurovascular devices/interventional neurology market is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neuro thrombectomy devices. The aneurysm coiling & embolization devices product segment, by type, is further segmented into embolic coils, flow diversion devices, and liquid embolic agents. The aneurysm coiling & embolization devices segment is estimated to account for the largest share of the neurovascular devices/interventional neurology market, by product, in 2021, owing to growing end-user preference for minimally invasive neurosurgical procedures and increasing market availability of embolic coils for neurovascular treatment.

"The cerebral aneurysm segment is estimated to account for the largest share of the global neurovascular devices/interventional neurology market from 2021 to 2026."

On the basis of pathology, the neurovascular devices/interventional neurology market is segmented into ischemic strokes, cerebral aneurysm, carotid artery stenosis, arteriovenous malformations & fistulas, and other diseases (including cavernous malformations and Moyamoya disease, among others). The cerebral aneurysm segment is estimated to account for the largest share of the global neurovascular devices/interventional neurology market, by pathology, in 2021, led by the growing adoption of minimally invasive neurosurgical procedures among neurosurgeons, increasing healthcare expenditure in emerging countries, and increasing incidence of risk factors (such as high blood pressure, cigarette smoking, high cholesterol, diabetes, and obesity).

"The ambulatory care centers segment is expected to grow at the highest CAGR from 2021 to 2026."

Based on end-user, the neurovascular devices/interventional neurology market has been segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories, and academic institutes. As of 2020, hospitals & surgical centers are estimated to account for the largest share of the global neurovascular devices/interventional neurology market in 2021, while ambulatory care centers are projected to register the highest CAGR during the forecast period. Growing patient preference for minimally invasive medical procedures, rising number of ambulatory surgery centers across developed countries, along with the ease of scheduling, the focused clinical staff, the improved productivity, and the increased safety, and efficacy of these centers, are the major factors that are expected to drive the growth of this end-user segment in the coming years.

"North America: The largest market in the neurovascular devices/interventional neurology industry."

North America accounted for the largest market share in the neurovascular devices/interventional neurology market in 2020. The neurovascular devices/interventional neurology market in North America is driven primarily by factors such as the growing target patient population for neurovascular diseases, rising awareness among neurosurgeons regarding the benefits offered by interventional neurology devices, and ongoing government initiatives to modernize & expand healthcare infrastructure. Additionally, the adoption of these devices has increased due to falling product prices, thereby further supporting the market growth in this region.

Breakdown of Primaries:

In-depth interviews have been conducted with various key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information, as well as to assess future market prospects. The distribution of primary interviews is as follows:

  • By Company Type: Tier 1- 48%, Tier 2- 36%, and Tier 3- 16%
  • By Designation: C-Level- 10%, Director Level- 14%, and Others- 76%
  • By Region: North America - 40%, Europe - 32%, Asia Pacific - 20%, Lain America - 5%, Middle East & Africa - 3%

Others include sales managers, engineers, and regional managers.

Note: Tier 1 Company-Revenue > USD 5 billion, Tier 2 Company-Revenue between USD 1 and USD 5 billion, and Tier 3 Company-Revenue < USD 1 billion

The neurovascular devices/interventional neurology market is dominated by a few major players that have an extensive country presence such as Johnson & Johnson (US), Medtronic PLC (Ireland), Stryker Corporation (US), Terumo Corporation (Japan), Penumbra, Inc. (US), and MicroPort Scientific Corporation (China) among others.

Research Coverage:

The report defines, describes, and forecasts the neurovascular devices/interventional neurology market, by product, disease pathology, end-user, and region. It also offers a detailed qualitative and quantitative analysis of the market. The report provides a comprehensive review of the major market drivers, restraints, opportunities, and challenges. It also covers various important aspects of the market, which include the analysis of the competitive landscape, market dynamics, market estimates in terms of value and volume, and future trends in the neurovascular devices/interventional neurology market.

Why Buy this Report?

1. The report identifies and addresses the key markets for the neurovascular devices/interventional neurology market, which would help equipment manufacturers and service providers review the growth in demand.

2. The report helps system providers understand the pulse of the market and provides insights into drivers, restraints, opportunities, and challenges.

3. The report will help key players understand the strategies of their competitors better and help them in making better strategic decisions.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SEGMENTATION
    • 1.3.2 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.3.3 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 VOLUME-BASED MARKET ESTIMATION
    • FIGURE 6 MARKET SIZE ESTIMATION: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 COVID-19 HEALTH ASSESSMENT
  • 2.4 COVID-19 ECONOMIC ASSESSMENT
  • 2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
  • 2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
  • 2.7 DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION
  • 2.8 RESEARCH ASSUMPTIONS
  • 2.9 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 11 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 HOSPITALS & SURGICAL CENTERS TO LEAD IN NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY APPLICATIONS DURING THE FORECAST PERIOD
    • FIGURE 14 NORTH AMERICA TO DOMINATE THE NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET DURING THE FORECAST PERIOD

4 PREMIUM INSIGHTS

  • 4.1 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET OVERVIEW
    • FIGURE 15 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET DEMAND FOR INTERVENTIONAL NEUROLOGY PRODUCTS
  • 4.2 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
    • FIGURE 16 EUROPE: ANEURYSM COILING & EMBOLIZATION DEVICES TO LEAD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
  • 4.3 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY PRODUCT MARKET, BY REGION
    • FIGURE 17 EMBOLIC COILS TO LEAD THE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
  • 4.4 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY
    • FIGURE 18 CEREBRAL ANEURYSM TO DOMINATE NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY, 2021 VS. 2026
  • 4.5 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY
    • FIGURE 19 CHINA AND INDIA TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 NEUROVASCULAR /INTERVENTIONAL NEUROLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Large target patient population
    • FIGURE 21 PROPORTION OF GERIATRIC POPULATION TO TOTAL WORLD POPULATION, BY COUNTRY, 2020 VS. 2030 (MILLION PEOPLE)
      • 5.2.1.2 Increasing product launches and commercialization
    • TABLE 2 PRODUCT APPROVALS IN THE NEUROVASCULAR DEVICES MARKET, 2020-2021
      • 5.2.1.3 Favorable reimbursement scenario
    • TABLE 3 US: REIMBURSEMENT FOR INTERVENTIONAL NEUROLOGY PROCEDURES, 2020
      • 5.2.1.4 Expansion of healthcare infrastructure across emerging markets
    • FIGURE 22 GLOBAL TREND IN GOVERNMENT HEALTHCARE EXPENDITURE (GDP): DEVELOPED VS. DEVELOPING COUNTRIES, 2015 VS. 2019
      • 5.2.1.5 Growth in market demand for effective neurovascular devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Dearth of skilled neurosurgeons
      • 5.2.2.2 High procedural cost of neurovascular surgeries and related products
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increase in the number of research activities in the field of neurovascular therapies
    • FIGURE 23 ONGOING CLINICAL TRIALS IN THE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
      • 5.2.3.2 Rise in demand for minimally invasive neurosurgical procedures
    • 5.2.4 CHALLENGE
      • 5.2.4.1 Stringent regulations
  • 5.3 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 SUPPLY CHAIN ANALYSIS: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2020
    • 5.3.1 ROLE IN SUPPLY CHAIN
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 25 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING THE REGULATION AND DISTRIBUTION STAGES
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 OVERVIEW
    • TABLE 4 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.6.2 THREAT OF NEW ENTRANTS
    • FIGURE 26 THREAT OF NEW ENTRANTS
    • 5.6.3 THREAT OF SUBSTITUTES
    • FIGURE 27 THREAT OF SUBSTITUTES
    • 5.6.4 BARGAINING POWER OF SUPPLIERS
    • FIGURE 28 BARGAINING POWER OF SUPPLIERS
    • 5.6.5 BARGAINING POWER OF BUYERS
    • FIGURE 29 BARGAINING POWER OF BUYERS
    • 5.6.6 DEGREE OF COMPETITION
    • FIGURE 30 DEGREE OF COMPETITION
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 NORTH AMERICA
      • 5.7.1.1 US
    • TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.7.1.2 Canada
    • 5.7.2 EUROPE
    • 5.7.3 APAC
      • 5.7.3.1 China
      • 5.7.3.2 Japan
      • 5.7.3.3 India
      • 5.7.3.4 South Korea
  • 5.8 REIMBURSEMENT SCENARIO
    • TABLE 7 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2019
  • 5.9 PRICING TREND ANALYSIS
    • TABLE 8 AVERAGE PRICE OF NEUROVASCULAR DEVICES, BY COUNTRY, 2020 (USD)
  • 5.10 COVID-19 IMPACT ON NEUROVASCULAR/INTERVENTIONAL NEUROLOGY DEVICES MARKET
  • 5.11 PATENT DETAILS
    • TABLE 9 PATENT DETAILS
    • FIGURE 31 PATENT ANALYSIS, 2011-2021

6 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 10 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 11 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (UNITS)
  • 6.2 ANEURYSM COILING & EMBOLIZATION DEVICES
    • TABLE 12 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 13 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (UNITS)
    • TABLE 14 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 15 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 16 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.1 EMBOLIC COILS
    • TABLE 17 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 18 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 19 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY REGION, 2019-2026 (UNITS)
      • 6.2.1.1 Bare detachable coils
        • 6.2.1.1.1 Clinical concerns related to the recurrence of brain aneurysms after treatment with bare detachable coils to limit the demand
    • TABLE 20 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR BARE DETACHABLE COILS, BY REGION, 2019-2026 (USD MILLION)
      • 6.2.1.2 Coated detachable coils
        • 6.2.1.2.1 High product prices to limit adoption in the forecast period
    • TABLE 21 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR COATED DETACHABLE COILS, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.2 FLOW DIVERSION DEVICES
      • 6.2.2.1 Increase in R&D activities for flow diverters to support demand in the forecast period
    • TABLE 22 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR FLOW DIVERSION DEVICES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 23 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR FLOW DIVERSION DEVICES, BY REGION, 2019-2026 (UNITS)
    • 6.2.3 LIQUID EMBOLIC AGENTS
      • 6.2.3.1 Growth in application in the treatment of AVM & AVF to propel demand
    • TABLE 24 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR LIQUID EMBOLIC AGENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 25 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR LIQUID EMBOLIC AGENTS, BY REGION, 2019-2026 (UNITS)
  • 6.3 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS
    • TABLE 26 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 27 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY TYPE, 2019-2026 (UNITS)
    • TABLE 28 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 29 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 30 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 6.3.1 CAROTID ARTERY STENTS
      • 6.3.1.1 Rise in public-private research funding to support innovative product development
    • TABLE 31 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR CAROTID ARTERY STENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 32 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR CAROTID ARTERY STENTS, BY REGION, 2019-2026 (UNITS)
    • 6.3.2 EMBOLIC PROTECTION DEVICES
      • 6.3.2.1 Associated technical limitations to restrain the market growth
    • TABLE 33 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR EMBOLIC PROTECTION DEVICES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 34 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR DISTAL FILTER DEVICES, BY REGION, 2019-2026 (UNITS)
    • 6.3.3 BALLOON CATHETERS
      • 6.3.3.1 Availability of specialized products to support market growth
    • TABLE 35 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEM MARKET SIZE FOR BALLOON CATHETER, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 36 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEM MARKET SIZE FOR BALLOON CATHETER, BY REGION, 2019-2026 (UNITS)
  • 6.4 SUPPORT DEVICES
    • TABLE 37 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR SUPPORT DEVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 38 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR SUPPORT DEVICES, BY TYPE, 2019-2026 (UNITS)
    • TABLE 39 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR SUPPORT DEVICES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 40 SUPPORT DEVICES SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 41 SUPPORT DEVICES SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 6.4.1 MICROCATHETERS
      • 6.4.1.1 Ongoing technological advancements in the field of neurovascular microcatheters to support market growth
    • TABLE 42 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR MICROCATHETERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 43 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR MICROCATHETERS, BY REGION, 2019-2026 (UNITS)
    • 6.4.2 GUIDEWIRES
      • 6.4.2.1 Higher application in stenting procedures to support market growth
    • TABLE 44 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR GUIDEWIRES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 45 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR GUIDEWIRES, BY REGION, 2019-2026 (UNITS)
  • 6.5 NEUROTHROMBECTOMY DEVICES
    • TABLE 46 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 47 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE, 2019-2026 (UNITS)
    • TABLE 48 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 49 NEUROTHROMBECTOMY DEVICES SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 50 NEUROTHROMBECTOMY DEVICES SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 6.5.1 CLOT RETRIEVAL DEVICES
      • 6.5.1.1 Greater availability of innovative stent clot retrievers to promote demand in the forecast period
    • TABLE 51 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR CLOT RETRIEVERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 52 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR CLOT RETRIEVERS, BY REGION, 2019-2026 (UNITS)
    • 6.5.2 SUCTION & ASPIRATION DEVICES
      • 6.5.2.1 Development and commercialization of novel devices to support market growth
    • TABLE 53 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 54 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2019-2026 (UNITS)
    • 6.5.3 SNARES
      • 6.5.3.1 Limited procedural benefits to limit the adoption in the forecast period
    • TABLE 55 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SNARES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 56 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SNARES, BY REGION, 2019-2026 (UNITS)

7 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY

  • 7.1 INTRODUCTION
    • TABLE 57 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 58 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.2 CEREBRAL ANEURYSMS
    • 7.2.1 HIGH RISK OF ANEURYSM RECURRENCE AFTER COILING PROCEDURE TO SUPPORT MARKET GROWTH
    • TABLE 59 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR CEREBRAL ANEURYSMS, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 ISCHEMIC STROKES
    • 7.3.1 GROWTH IN THE NUMBER OF PATIENTS SUFFERING FROM STROKES TO INCREASE THE DEMAND FOR NEUROVASCULAR DEVICES
    • TABLE 60 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR ISCHEMIC STROKES, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 CAROTID ARTERY STENOSIS
    • 7.4.1 RISE IN THE OCCURENCE OF ARTERY STENOSES TO BOOST THE MARKET
    • TABLE 61 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR CAROTID ARTERY STENOSIS, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 ARTERIOVENOUS MALFORMATION & FISTULAS
    • 7.5.1 LACK OF SKILLED NEUROSURGEONS CAN RESTRAIN MARKET GROWTH
    • TABLE 62 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 OTHER DISEASE PATHOLOGIES
    • 7.6.1 INCREASE IN THE PATIENT POPULATION FOR TARGET DISEASES TO BOOST THE MARKET
    • TABLE 63 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR OTHER DISEASE PATHOLOGIES, BY REGION, 2019-2026 (USD MILLION)

8 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 64 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
  • 8.2 HOSPITALS & SURGICAL CENTERS
    • 8.2.1 LARGEST END USERS OF NEUROVASCULAR DEVICES
    • TABLE 65 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE IN HOSPITALS & SURGICAL CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 AMBULATORY CARE CENTERS
    • 8.3.1 INCREASE IN THE NUMBER OF ACCS LIKELY TO BOOST THE MARKET
    • TABLE 66 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE IN AMBULATORY CARE CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
    • 8.4.1 ONGOING DEVELOPMENT OF COST-EFFECTIVE AND TECHNOLOGICALLY ADVANCED DEVICES TO SUPPORT THE GROWTH OF THIS SEGMENT
    • TABLE 67 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE IN RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2019-2026 (USD MILLION)

9 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 68 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • TABLE 69 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 70 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 71 NORTH AMERICA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 72 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 73 NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 74 NORTH AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 75 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 76 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 77 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • FIGURE 32 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT
    • 9.2.1 US
      • 9.2.1.1 Largest share of the North American market
    • TABLE 78 US: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 79 US: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 80 US: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 81 US: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 82 US: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 83 US: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 The high incidence of neurovascular diseases to support market growth
    • TABLE 84 CANADA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 85 CANADA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 86 CANADA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 87 CANADA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 88 CANADA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 89 CANADA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 90 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 91 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 92 EUROPE: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 93 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 94 EUROPE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 95 EUROPE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 96 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 97 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 98 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Largest share of the market in Europe in 2020
    • TABLE 99 GERMANY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 100 GERMANY: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 101 GERMANY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 GERMANY: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 103 GERMANY: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 104 GERMANY: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Increase in awareness in the country regarding incidences of strokes
    • TABLE 105 FRANCE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 106 FRANCE: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 107 FRANCE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 108 FRANCE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 109 FRANCE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 110 FRANCE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Growth in government initiatives to support market demand
    • TABLE 111 UK: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 112 UK: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 113 UK: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 114 UK: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 115 UK: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 116 UK: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Well-established healthcare infrastructure to aid the growth of the neurovascular devices market
    • TABLE 117 ITALY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 118 ITALY: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 119 ITALY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 120 ITALY: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 121 ITALY: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 122 ITALY: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Rise in the number of clinical trials to support the growth of the neurovascular devices market
    • TABLE 123 SPAIN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 124 SPAIN: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 125 SPAIN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 126 SPAIN: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 127 SPAIN: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 128 SPAIN: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 129 ROE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 130 ROE: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 131 ROE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 132 ROE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 133 ROE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 134 ROE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
  • 9.4 APAC
    • TABLE 135 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 136 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 137 APAC: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 138 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 APAC: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 140 APAC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 141 APAC: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 142 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 143 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • FIGURE 33 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT
    • 9.4.1 JAPAN
      • 9.4.1.1 Favorable reimbursement policy in the country to support market growth
    • TABLE 144 JAPAN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 145 JAPAN: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 146 JAPAN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 147 JAPAN: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 148 JAPAN: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 149 JAPAN: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Expansion by key market players in the region to drive market growth
    • TABLE 150 CHINA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 151 CHINA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 152 CHINA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 153 CHINA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 154 CHINA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 155 CHINA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Increase in government initiatives to support the demand for neurovascular devices
    • TABLE 156 INDIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 157 INDIA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 158 INDIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 159 INDIA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 160 INDIA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 161 INDIA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Rise in disease prevalence Australia to augment market demand
    • TABLE 162 AUSTRALIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 163 AUSTRALIA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 164 AUSTRALIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 165 AUSTRALIA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 166 AUSTRALIA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 167 AUSTRALIA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.4.5 SOUTH KOREA
      • 9.4.5.1 Supportive government initiatives to drive the neurovascular devices market
    • TABLE 168 SOUTH KOREA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 169 SOUTH KOREA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 170 SOUTH KOREA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 171 SOUTH KOREA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 172 SOUTH KOREA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 173 SOUTH KOREA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.4.6 REST OF APAC
    • TABLE 174 ROAPAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 175 ROAPAC: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 176 RAPAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 177 ROAPAC: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 178 ROAPAC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 179 ROAPAC: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 180 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 181 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 182 LATIN AMERICA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 183 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 184 LATIN AMERICA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 185 LATIN AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 186 LATIN AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 187 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 188 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 9.5.1 BRAZIL
      • 9.5.1.1 Increase in awareness about neurovascular devices to increase the demand in Brazil
    • TABLE 189 BRAZIL: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 190 BRAZIL: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 191 BRAZIL: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 192 BRAZIL: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 193 BRAZIL: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 194 BRAZIL: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.5.2 MEXICO
      • 9.5.2.1 Growth in patient population to lead to market growth
    • TABLE 195 MEXICO: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 196 MEXICO: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 197 MEXICO: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 198 MEXICO: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 199 MEXICO: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 200 MEXICO: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • 9.5.3 REST OF LATIN AMERICA
    • TABLE 201 ROLATAM: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 202 ROLATAM: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 203 ROLATAM: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 204 ROLATAM: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 205 ROLATAM: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 206 ROLATAM: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • TABLE 207 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 208 MIDDLE EAST & AFRICA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 209 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 210 MIDDLE EAST & AFRICA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 211 MIDDLE EAST & AFRICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 212 MIDDLE EAST & AFRICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 213 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION)
    • TABLE 214 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 34 KEY PLAYER STRATEGIES
  • 10.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
  • 10.3 MARKET SHARE ANALYSIS
    • TABLE 215 NEUROVASCULAR DEVICES MARKET: DEGREE OF COMPETITION, 2020
    • FIGURE 36 STRYKER CORPORATION HELD THE LEADING POSITION IN THE NEUROVASCULAR DEVICES MARKET IN 2020
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (KEY PLAYERS)
    • 10.4.1 STARS
    • 10.4.2 EMERGING LEADERS
    • 10.4.3 PERVASIVE PLAYERS
    • 10.4.4 PARTICIPANTS
    • FIGURE 37 NEUROVASCULAR DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (KEY PLAYERS), 2019
  • 10.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 STARTING BLOCKS
    • 10.5.3 RESPONSIVE COMPANIES
    • 10.5.4 DYNAMIC COMPANIES
    • FIGURE 38 NEUROVASCULAR DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SME, 2020
  • 10.6 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE NEUROVASCULAR DEVICES MARKET
    • TABLE 216 INDUSTRY AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE NEUROVASCULAR DEVICES MARKET
    • TABLE 217 COMPANY INDUSTRY FOOTPRINT
    • TABLE 218 COMPANY REGION FOOTPRINT
    • 10.6.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
    • TABLE 219 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS, JANUARY 2018-MARCH 2021
    • 10.6.2 DEALS
    • TABLE 220 KEY DEALS, JANUARY 2018-MARCH 2021
    • 10.6.3 OTHER DEVELOPMENTS
    • TABLE 221 OTHER KEY DEVELOPMENTS, JANUARY 2018-MARCH 2021

11 COMPANY PROFILES

  • (Business overview, Products offered, Recent developments & MnM View)**
  • 11.1 KEY PLAYERS
    • 11.1.1 STRYKER CORPORATION
    • TABLE 222 STRYKER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 39 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 223 STRYKER CORPORATION: PRODUCT OFFERED
    • 11.1.2 MEDTRONIC PLC
    • TABLE 224 MEDTRONIC PLC: BUSINESS OVERVIEW
    • FIGURE 40 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
    • TABLE 225 MEDTRONIC PLC: PRODUCT OFFERED
    • 11.1.3 JOHNSON & JOHNSON
    • TABLE 226 JOHNSON & JOHNSON: BUSINESS OVERVIEW
    • FIGURE 41 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
    • TABLE 227 JOHNSON & JOHNSON: PRODUCT OFFERED
    • 11.1.4 TERUMO
    • TABLE 228 TERUMO: BUSINESS OVERVIEW
    • FIGURE 42 TERUMO: COMPANY SNAPSHOT (2019)
    • TABLE 229 TERUMO: PRODUCT OFFERED
    • 11.1.5 PENUMBRA
    • TABLE 230 PENUMBRA: BUSINESS OVERVIEW
    • FIGURE 43 PENUMBRA: COMPANY SNAPSHOT (2020)
    • TABLE 231 PENUMBRA: PRODUCT OFFERED
    • 11.1.6 MICROPORT SCIENTIFIC CORPORATION
    • TABLE 232 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 44 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
    • TABLE 233 MICROPORT SCIENTIFIC CORPORATION: PRODUCT OFFERED
    • 11.1.7 MEDIKIT CO. LTD.
    • TABLE 234 MEDIKIT CO. LTD.: BUSINESS OVERVIEW
    • FIGURE 45 MEDIKIT CO. LTD.: COMPANY SNAPSHOT (2020)
    • TABLE 235 MEDIKIT CO. LTD.: PRODUCT OFFERED
    • 11.1.8 INTEGERS HOLDING CORPORATION
    • TABLE 236 INTEGERS HOLDING CORPORATION: BUSINESS OVERVIEW
    • FIGURE 46 INTEGERS HOLDING CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 237 INTEGERS HOLDING CORPORATION: PRODUCT OFFERED
    • 11.1.9 BALT
    • TABLE 238 BALT: BUSINESS OVERVIEW
    • TABLE 239 BALT: PRODUCT OFFERED
    • 11.1.10 KANEKA CORPORATION
    • TABLE 240 KANEKA CORPORATION: COMPANY AT A GLANCE
    • FIGURE 47 KANEKA CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 241 KANEKA CORPORATION: PRODUCT OFFERED
    • 11.1.11 PHENOX GMBH
    • TABLE 242 PHENOX: BUSINESS OVERVIEW
    • TABLE 243 PHENOX: PRODUCT OFFERED
    • 11.1.12 ASAHI INTECC
    • TABLE 244 ASAHI INTECC: BUSINESS OVERVIEW
    • FIGURE 48 ASAHI INTECC: COMPANY SNAPSHOT (2020)
    • TABLE 245 ASAHI INTECC: PRODUCT OFFERED
    • 11.1.13 PERFLOW MEDICAL
    • TABLE 246 PERFLOW MEDICAL: BUSINESS OVERVIEW
    • TABLE 247 PERFLOW MEDICAL: PRODUCT OFFERED
    • 11.1.14 RAPID MEDICAL
    • TABLE 248 RAPID MEDICAL: BUSINESS OVERVIEW
    • TABLE 249 RAPID MEDICAL: PRODUCT OFFERED
    • 11.1.15 CERUS ENDOVASCULAR
    • TABLE 250 CERUS ENDOVASCULAR: BUSINESS OVERVIEW
    • TABLE 251 CERUS ENDOVASCULAR: PRODUCT OFFERED
    • 11.1.16 ACANDIS GMBH
    • TABLE 252 ACANDIS GMBH: BUSINESS OVERVIEW
    • TABLE 253 ACANDIS GMBH: PRODUCT OFFERED
    • 11.1.17 EVASC
    • TABLE 254 EVASC: BUSINESS OVERVIEW
    • TABLE 255 EVASC: PRODUCT OFFERED
    • 11.1.18 SENSOME
    • TABLE 256 SENSOME: BUSINESS OVERVIEW
    • TABLE 257 SENSOME: PRODUCT OFFERED
    • 11.1.19 LEPU MEDICAL
    • TABLE 258 LEPU MEDICAL: BUSINESS OVERVIEW
    • FIGURE 49 LEPU MEDICAL: COMPANY SNAPSHOT (2019)
    • TABLE 259 LEPU MEDICAL: PRODUCT OFFERED
    • 11.1.20 IMPERATIVE CARE
    • TABLE 260 IMPERATIVE CARE: BUSINESS OVERVIEW
    • TABLE 261 IMPERATIVE CARE: PRODUCT OFFERED
  • *Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS